glp-1 agonist therapy Receptor Agonists: The New Wave in Diabetes Management Evolution of GLP‐1 Receptor Agonists

7 In the gut, GLP-1RAs enhance epithelial barrier integrity and downregulate pro-inflammatory cytokines

You can book a consultation with an endocrinologist or diabetologist on Quickobook for safe, evidence-based guidance

GLP-1 medications are currently considered long-term treatments

Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

It's hard to make injections

Also, the NGT relies on expert consensus rather than objective clinical research data, is subject to personal interpretation, may be influenced by factors such as hospital or healthcare system policies, and does not account for long-term outcomes, cost analyses, or adverse effects